DE60025650D1 - Farnesyltransferase inhibitoren - Google Patents

Farnesyltransferase inhibitoren

Info

Publication number
DE60025650D1
DE60025650D1 DE60025650T DE60025650T DE60025650D1 DE 60025650 D1 DE60025650 D1 DE 60025650D1 DE 60025650 T DE60025650 T DE 60025650T DE 60025650 T DE60025650 T DE 60025650T DE 60025650 D1 DE60025650 D1 DE 60025650D1
Authority
DE
Germany
Prior art keywords
transferase inhibitors
farnesyl transferase
farnesyl
inhibitors
transferase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025650T
Other languages
English (en)
Inventor
Francis Thomas Boyle
James Michael Wardleworth
Zbigniew Matusiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE60025650D1 publication Critical patent/DE60025650D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60025650T 1999-12-22 2000-12-18 Farnesyltransferase inhibitoren Expired - Lifetime DE60025650D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930318.2A GB9930318D0 (en) 1999-12-22 1999-12-22 Novel compounds
PCT/GB2000/004856 WO2001046137A1 (en) 1999-12-22 2000-12-18 Farnesyl transferase inhibitors

Publications (1)

Publication Number Publication Date
DE60025650D1 true DE60025650D1 (de) 2006-04-06

Family

ID=10866834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025650T Expired - Lifetime DE60025650D1 (de) 1999-12-22 2000-12-18 Farnesyltransferase inhibitoren

Country Status (27)

Country Link
US (1) US7101897B2 (de)
EP (1) EP1255733B1 (de)
JP (1) JP3742593B2 (de)
KR (1) KR20020063251A (de)
CN (2) CN1229344C (de)
AR (1) AR029460A1 (de)
AT (1) ATE316074T1 (de)
AU (1) AU776003B2 (de)
BR (1) BR0016669A (de)
CA (1) CA2387579A1 (de)
CO (1) CO5360641A1 (de)
CZ (1) CZ20022125A3 (de)
DE (1) DE60025650D1 (de)
EE (1) EE200200206A (de)
GB (1) GB9930318D0 (de)
HU (1) HUP0204135A3 (de)
IL (1) IL149871A0 (de)
IS (1) IS6358A (de)
MX (1) MXPA02005981A (de)
MY (1) MY133606A (de)
NO (1) NO20022924L (de)
NZ (1) NZ518341A (de)
PL (1) PL355887A1 (de)
RU (1) RU2259997C2 (de)
SK (1) SK8642002A3 (de)
WO (1) WO2001046137A1 (de)
ZA (1) ZA200202694B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117864A1 (en) * 2004-05-28 2005-12-15 Astrazeneca Ab Combination product comprising anastrozole and a dual prenyl transferase inhibitor
CN101072783A (zh) * 2004-10-08 2007-11-14 寿制药株式会社 膦酸衍生物以及与血液高磷酸相关的疾病的治疗药
WO2007092285A2 (en) * 2006-02-02 2007-08-16 Link Medicine Corporation Treatment of synucleinopathies
US8232402B2 (en) 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
EP2370436A1 (de) 2008-11-13 2011-10-05 Link Medicine Corporation Azachinolinonderivate und deren verwendungen
JP2012520884A (ja) 2009-03-18 2012-09-10 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニバーシティー フラビウイルス科ウイルス感染症を治療する方法および組成物
WO2011088126A2 (en) * 2010-01-13 2011-07-21 Eiger Biopharmaceuticals, Inc. Treatment of viral infection with prenyltransferase inhibitors

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60233076A (ja) 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
DE3579888D1 (de) 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
KR880006244A (ko) 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
GB8921635D0 (en) 1989-09-25 1989-11-08 Fujisawa Pharmaceutical Co 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives
CA2036163C (en) 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
IE910606A1 (en) 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
GB9107363D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
US6083917A (en) 1990-04-18 2000-07-04 Board Of Regents, The University Of Texas System Methods and compositions for the identification, characterization and inhibition of farnesyltransferase
US5185248A (en) * 1990-05-08 1993-02-09 E. R. Squibb & Sons, Inc. Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation
JPH0578360A (ja) 1991-01-31 1993-03-30 Banyu Pharmaceut Co Ltd ２−［２−（スルフアモイルアルキル）ピロリジニルチオカルバペネム誘導体
GB9107342D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107341D0 (en) 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
RU2093514C1 (ru) 1991-06-04 1997-10-20 Санкио Компани Лимитед Производные 1-метилкарбапенема и способ их получения
JPH04368386A (ja) 1991-06-18 1992-12-21 Sankyo Co Ltd １−メチルカルバペネム−３−カルボン酸の製造法
US5360798A (en) 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
DK0537007T3 (da) 1991-10-11 1995-09-25 Squibb & Sons Inc Anvendelse af farnesyl-protein-transferase-inhibitorer til fremstilling af et lægemiddel til blokering af neoplastisk transformation af celler fremkaldt af ras-oncogener
JPH05239058A (ja) 1991-12-17 1993-09-17 Fujisawa Pharmaceut Co Ltd ３−ピロリジニルチオ−１−アザビシクロ［３．２．０ヘプト−２−エン−２−カルボン酸化合物
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CZ290002B6 (cs) 1992-03-11 2002-05-15 Sankyo Company Limited Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek
GB9304156D0 (en) 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2091309A1 (en) 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
WO1993021186A1 (en) 1992-04-13 1993-10-28 Fujisawa Pharmaceutical Co., Ltd. Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents
EP0581502B1 (de) 1992-07-21 1998-10-21 Zeneca Limited Antibiotische carbapenemverbindungen
CA2099818A1 (en) 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
EP0581501B1 (de) 1992-07-21 1998-09-09 Zeneca Limited Antibiotische Carbapenemverbindungen
EP0590885B1 (de) 1992-09-28 2000-03-15 Zeneca Limited Antibiotische Carbapenemverbindungen
CA2106330A1 (en) 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
CA2118985A1 (en) 1993-04-02 1994-10-03 Dinesh V. Patel Heterocyclic inhibitors of farnesyl protein transferase
CA2165176A1 (en) 1993-06-18 1995-01-05 Samuel L. Graham Inhibitors of farnesyl-protein transferase
JP2534823B2 (ja) 1993-07-07 1996-09-18 日本電気株式会社 印刷装置
US5468733A (en) 1993-09-30 1995-11-21 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5576293A (en) 1993-09-30 1996-11-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
CA2155448A1 (en) 1994-08-11 1996-02-12 Katerina Leftheris Inhibitors of farnesyl protein transferase
US5571835A (en) 1994-09-29 1996-11-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU706008B2 (en) 1995-03-29 1999-06-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
ES2196163T3 (es) 1995-07-31 2003-12-16 Shionogi & Co Derivados de pirrolidina con una actividad de inhibicion de la fosfolipasa a2.
GB9515975D0 (en) * 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
JPH1050029A (ja) 1996-05-28 1998-02-20 Nobuyuki Higuchi 情報記憶装置
WO1998007692A1 (en) * 1996-08-17 1998-02-26 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
WO1998032741A1 (en) * 1997-01-29 1998-07-30 Zeneca Limited Inhibitors of farnesyl protein transferase
CA2288330C (en) 1997-05-07 2014-02-11 University Of Pittsburgh Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
WO1999041235A1 (en) 1998-02-10 1999-08-19 Astrazeneca Uk Limited Farnesyl transferase inhibitors

Also Published As

Publication number Publication date
ATE316074T1 (de) 2006-02-15
CN1411442A (zh) 2003-04-16
HUP0204135A2 (hu) 2003-03-28
SK8642002A3 (en) 2002-12-03
KR20020063251A (ko) 2002-08-01
AU2201301A (en) 2001-07-03
NO20022924D0 (no) 2002-06-18
JP3742593B2 (ja) 2006-02-08
US20030083348A1 (en) 2003-05-01
CZ20022125A3 (cs) 2002-09-11
IL149871A0 (en) 2002-11-10
RU2002119405A (ru) 2004-01-10
EP1255733A1 (de) 2002-11-13
EP1255733B1 (de) 2006-01-18
CN1680313A (zh) 2005-10-12
MY133606A (en) 2007-11-30
ZA200202694B (en) 2003-12-31
GB9930318D0 (en) 2000-02-09
NO20022924L (no) 2002-06-18
CN1229344C (zh) 2005-11-30
HUP0204135A3 (en) 2005-03-29
US7101897B2 (en) 2006-09-05
BR0016669A (pt) 2002-10-08
NZ518341A (en) 2004-01-30
JP2003518091A (ja) 2003-06-03
MXPA02005981A (es) 2005-07-01
PL355887A1 (en) 2004-05-31
CO5360641A1 (es) 2004-01-30
WO2001046137A1 (en) 2001-06-28
AU776003B2 (en) 2004-08-19
CA2387579A1 (en) 2001-06-28
EE200200206A (et) 2003-04-15
RU2259997C2 (ru) 2005-09-10
IS6358A (is) 2002-04-23
AR029460A1 (es) 2003-07-02

Similar Documents

Publication Publication Date Title
PT1226136E (pt) Inibidores da tirosina quinase
PT1181017E (pt) Inibidores de metaloproteases
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
ATE524441T1 (de) Vla-4-inhibitoren
NO20021239D0 (no) Pteridinoner som kinase-inhibitorer
DE69618999D1 (de) Farnesyltransferase hemmende 2-chinolonderivate
NO20012960L (no) Farnesylproteintransferase-inhibitorer
ATE323681T1 (de) Farnesyltransferase inhibitoren
ATE316074T1 (de) Farnesyltransferase inhibitoren
DE60009260D1 (de) Thiopyranderivate as mmp-inhibitoren
NO20012961D0 (no) Trisykliske farnesylproteintransferase-inhibitorer
DE69711081D1 (de) Farnesyl transferase inhibitoren
AU3514302A (en) 0ovel farnesyl protein transferase inhibitors
NO20006314D0 (no) Prenyltransferase-inhibitorer
ATE263229T1 (de) Enzymatischer vergrauungsinhibitor
NO20022923L (no) Inhibitorer av farnesyl-protein-transferase
IDP000027420A (id) Inhibitor-inhibitor kinase pirolotriazin

Legal Events

Date Code Title Description
8332 No legal effect for de